• 1
    Wang DQ-H, Afdhal NH. Genetic analysis of cholesterol gallstone formation: searching for Lith (gallstone) genes. Curr Gastroenterol Rep 2004; 6: 140150.
  • 2
    Paigen B, Carey MC. Gallstones. In: KingRA, RotterJF, MotulskyAG, eds. The Genetic Basis of Common Diseases. 1st ed. New York: Oxford University Press, 2002: 298335.
  • 3
    Schwartz CC, Halloran LG, Vlahcevic ZR. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. Science 1978; 200: 6264.
  • 4
    Robins SJ, Fasulo JM. High density lipoproteins, but not other lipoproteins, provide a vehicle for sterol transport to bile. J Clin Invest 1997; 99: 380384.
  • 5
    Dijk MCM, Pieters M, van Berkel TJC. Kinetics of biliary secretion of chylomicron remnant cholesterol (esters) in the rat. Eur J Biochem 1993; 211: 781787.
  • 6
    Smit MJ, Kuipers F, Vonk RJ, Temmerman AM, Jäckle S, Windler EET. Effects of dietary cholesterol on bile formation and hepatic processing of chylomicron remnant cholesterol in the rat. HEPATOLOGY 1993; 17: 445454.
  • 7
    Bravo E, Guldur T, Botham KM, Mayes PA, Cantafora A. Hepatic uptake and processing of cholesterol and cholesteryl ester from chylomicron remnants: an in vivo study in the rat. Biochim Biophys Acta 1992; 1123: 8593.
  • 8
    Wang DQ-H, Zhang L, Wang HH. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice. Biochim Biophys Acta 2005; 1733: 9099.
  • 9
    Juvonen T, Savolainen MJ, Kairaluoma MI, Lajunen LH, Humphries SE, Kesaniemi YA. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995; 36: 804812.
  • 10
    Han T, Jiang Z, Suo G, Zhang S. Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease. Clin Genet 2000; 57: 304308.
  • 11
    Fu X, Gong K, Shao X. The relationship between serum lipids, apolipoproteins level and bile lipids level, chemical type of stone. Zhonghua Yi Xue Za Zhi 1995; 75: 656659 [in Chinese].
  • 12
    Tan YF, Yang S, Yu RB, Shen C, Ding WL, Zhou WM, et al. Relationship among the XhaI and EcoRI locus polymorphisms of apolipoprotein B gene, serum lipid metabolism and gallstone disease. Zhonghua Yi Xue Za Zhi 2003; 83: 844847 [in Chinese].
  • 13
    Havel RJ, Kane JP. Introduction: structure and metabolism of plasma lipoproteins. In: ScriverCR, BeaudetAL, SlyWS, ValleD, eds. The Metabolic and Molecular Bases of Inherited Disease. Volume 2. 2nd ed. New York: McGraw-Hill, Inc., 1995: 18411851.
  • 14
    Young SG, Cham CM, Pitas RE, Burri BJ, Connolly A, Flynn L, et al. A genetic model for absent chylomicron formation: mice producing apolipoprotein B in the liver, but not in the intestine. J Clin Invest 1995; 96: 29322946.
  • 15
    Hamilton RL, Wong JS, Cham CM, Nielsen LB, Young SG. Chylomicron-sized lipid particles are formed in the setting of apolipoprotein B deficiency. J Lipid Res 1998; 39: 15431557.
  • 16
    Jäckle S, Rinninger F, Greeve J, Greten H, Windler E. Regulation of the hepatic removal of chylomicron remnants and β-very low density lipoproteins in the rat. J Lipid Res 1992; 33: 419429.
  • 17
    Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997; 38: 21732192.
  • 18
    Mahley RW, Hussain MM. Chylomicron and chylomicron remnant catabolism. Curr Opin Lipidol 1991; 2: 170176.
  • 19
    Farese RV Jr, Veniant MM, Cham CM, Flynn LM, Pierotti V, Loring JF, et al. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. Proc Natl Acad Sci U S A 1996; 93: 63936398.
  • 20
    Wang DQ-H, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 1997; 38: 13951411.
  • 21
    Wang DQ-H, Carey MC. Measurement of intestinal cholesterol absorption by plasma and fecal dual-isotope ratio, mass balance, and lymph fistula methods in the mouse: an analysis of direct versus indirect methodologies. J Lipid Res 2003; 44: 10421059.
  • 22
    Wang DQ-H, Lammert F, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: pathophysiology of biliary lipid secretion. J Lipid Res 1999; 40: 20662079.
  • 23
    Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem 1959; 234: 466468.
  • 24
    Rossi SS, Converse JL, Hofmann AF. High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987; 28: 589595.
  • 25
    Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978; 19: 945955.
  • 26
    Heuman DM. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30: 719730.
  • 27
    Nishina PM, Wang J, Toyofuku W, Kuypers FA, Ishida BY, Paigen B. Atherosclerosis and plasma and liver lipids in nine inbred strains of mice. Lipids 1993; 28: 599605.
  • 28
    Wang DQ-H, Paigen B, Carey MC. Genetic factors at the enterocyte level account for variations in intestinal cholesterol absorption efficiency among inbred strains of mice. J Lipid Res 2001; 42: 18201830.
  • 29
    Lammert F, Wang DQ-H, Paigen B, Carey MC. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: integrated activities of hepatic lipid regulatory enzymes. J Lipid Res 1999; 40: 20802090.
  • 30
    Hylemon PB, Studer EJ, Pandak WM, Heuman DM, Vlahcevic ZR, Chiang JY. Simultaneous measurement of cholesterol 7α-hydroxylase activity by reverse-phase high-performance liquid chromatography using both endogenous and exogenous [4-14C]cholesterol as substrate. Anal Biochem 1989; 182: 212216.
  • 31
    Kruit JK, Plosch T, Havinga R, Boverhof R, Groot PH, Groen AK, et al. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 2005; 128: 147156.
  • 32
    Jung HR, Turner SM, Neese RA, Young SG, Hellerstein MK. Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice. Biochem J 1999; 343: 473478.
  • 33
    Hillebrant CG, Nyberg B, Einarsson K, Eriksson M. The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans. Gut 1997; 41: 700704.
  • 34
    Srivastava RA, Srivastava N, Averna M. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Eur J Biochem 2000; 267: 42724280.
  • 35
    Hedrick CC, Hassan K, Hough GP, Yoo JH, Simzar S, Quinto CR, et al. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism. Arterioscler Thromb Vasc Biol 2000; 20: 19461952.
  • 36
    Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, et al. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 2002; 109: 961971.
  • 37
    Wang DQ-H, Tazuma S, Cohen DE, Carey MC. Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am J Physiol 2003; 285: G494G502.
  • 38
    Wang DQ-H, Carey MC. Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI. Biochim Biophys Acta 2002; 1583: 141150.
  • 39
    Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002; 110: 671680.
  • 40
    Amigo L, Quinones V, Mardones P, Zanlungo S, Miquel JF, Nervi F, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet. Gastroenterology 2000; 118: 772779.
  • 41
    Buhman KK, Accad M, Novak S, Choi RS, Wong JS, Hamilton RL, et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 2000; 6: 13411347.
  • 42
    Kesäniemi YA, Miettinen TA. Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population. Eur J Clin Invest 1987; 17: 391395.
  • 43
    Huang YC, Zhang XW, Yang RX. Changes in cholelithiasis in Tianjin in the past 30 years. Chin Med J 1984; 97: 133135.
  • 44
    Nakayama F, Miyake H. Changing state of gallstone disease in Japan. Am J Surg 1970; 120: 794799.
  • 45
    Nagase M, Tanimura H, Setoyama M, Hikasa Y. Present features of gallstones in Japan: a collective review of 2,144 cases. Am J Surg 1978; 135: 788790.